Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy

被引:29
|
作者
Romano, Maria [1 ,2 ]
Di Taranto, Maria Donata [3 ]
D'Agostino, Maria Nicoletta [1 ,2 ]
Marotta, Gennaro [4 ]
Gentile, Marco [4 ]
Abate, Giovanna [2 ]
Mirabelli, Peppino [1 ,2 ]
Di Noto, Rosa [1 ,2 ]
Del Vecchio, Luigi [1 ,2 ]
Rubba, Paolo [4 ]
Fortunato, Giuliana [1 ,2 ]
机构
[1] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy
[2] CEINGE SCarl Biotecnol Avanzate, Naples, Italy
[3] Fdn IRCCS SDN, Naples, Italy
[4] Univ Naples Federico 2, Dipartimento Med Clin & Sperimentale, Naples, Italy
关键词
LDL receptor; Familial hypercholesterolemia; Large rearrangements; LDL uptake assay; RECEPTOR GENE-MUTATIONS; POPULATION;
D O I
10.1016/j.atherosclerosis.2009.11.051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Autosomal dominant hypercholesterolemias are due to defects in the LDL receptor (LDLR) gene, in the apolipoprotein B-100 gene or in the proprotein convertase subtilisin/kexin type 9 gene. The aim of this study was to identify and functionally characterize mutations in the LDLR gene that account for most cases of familial hypercholesterolemia (FH). Methods: We enrolled 56 unrelated patients from Southern Italy with a clinical diagnosis of FH. The mutation screening was performed by direct sequencing of the promoter and the 18 exons of the LDLR gene and by multiplex ligation-dependent probe amplification (MLPA) analysis to search for large rearrangements. Results and conclusion: We found 5 new mutations, the causative role of which was demonstrated by functional characterization performed by quanti. cation of fluorescent LDL uptake in EBV-transformed B lymphocytes. These results enlarge the spectrum of FH-causative LDLR mutations. Lastly, screening for large rearrangements is highly recommended for the genetic diagnosis of FH. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:493 / 496
页数:4
相关论文
共 50 条
  • [31] Novel approaches to the detection of heterozygote LDLR mutations causing severe familial hypercholesterolemia
    Cantafora, A.
    Blotta, I.
    Pisciotta, L.
    Careri, R.
    Calandra, S.
    Bertolini, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 136 - 136
  • [32] Functional characterization of point mutations in the LDLR gene found in Portuguese patients with clinical diagnosis of familial hypercholesterolaemia.
    Silva, S.
    Patel, D.
    Bourbon, M.
    Soutar, A. K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 213 - 213
  • [33] Identification of novel variants in the LDLR gene in Russian patients with familial hypercholesterolemia using targeted sequencing
    Miroshnikova, Valentina V.
    Romanova, Olga V.
    Ivanova, Olga N.
    Fedyakov, Mikhail A.
    Panteleeva, Alexandra A.
    Barbitoff, Yury A.
    Muzalevskaya, Maria V.
    Urazgildeeva, Sorejya A.
    Gurevich, Victor S.
    Urazov, Stanislav P.
    Scherbak, Sergey G.
    Sarana, Andrey M.
    Semenova, Natalia A.
    Anisimova, Inga V.
    Guseva, Darya M.
    Pchelina, Sofya N.
    Glotov, Andrey S.
    Zakharova, Ekaterina Y.
    Glotov, Oleg S.
    BIOMEDICAL REPORTS, 2021, 14 (01) : 1 - 13
  • [34] Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia
    Xian Lv
    Chunyue Wang
    Lu Liu
    Guoqing Yin
    Wen Zhang
    Fuad A. Abdu
    Tingting Shi
    Qingfeng Zhang
    Wenliang Che
    Lipids in Health and Disease, 22
  • [35] Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients
    Slimani, Afef
    Jelassi, Awatef
    Jguirim, Imen
    Najah, Mohamed
    Rebhi, Lamia
    Omezzine, Asma
    Maatouk, Faouzi
    Ben Hamda, Khaldoun
    Kacem, Maha
    Rabes, Jean-Pierre
    Abifadel, Marianne
    Boileau, Catherine
    Rouis, Mustapha
    Slimane, Mohamed Naceur
    Varret, Mathilde
    ATHEROSCLEROSIS, 2012, 222 (01) : 158 - 166
  • [36] Screening and verifying the mutations in the LDLR and APOB genes in a Chinese family with familial hypercholesterolemia
    Lv, Xian
    Wang, Chunyue
    Liu, Lu
    Yin, Guoqing
    Zhang, Wen
    Abdu, Fuad A.
    Shi, Tingting
    Zhang, Qingfeng
    Che, Wenliang
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [37] Novel LDLR Variant in Familial Hypercholesterolemia: NGS-Based Identification, In Silico Characterization, and Pharmacogenetic Insights
    Athar, Mohammad
    Toonsi, Mawaddah
    Abduljaleel, Zainularifeen
    Bouazzaoui, Abdellatif
    Bogari, Neda M.
    Dannoun, Anas
    Al-Allaf, Faisal A.
    LIFE-BASEL, 2023, 13 (07):
  • [38] Advance in molecular diagnosis of familial hypercholesterolemia in the Czech population: Identification and characterization of large rearrangements in LDLR gene
    Kozak, L.
    Zapletalova, P.
    Goldmann, R.
    Letocha, O.
    Vyroubalova, L.
    Porupkova, J.
    Tichy, L.
    Freiberger, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 51 - 51
  • [39] Novel Mutations Identification in Exon 4 of LDLR Gene in Patients With Moderate Hypercholesterolemia in a Venezuelan Population
    Arraiz, Nailet
    Bermudez, Valmore
    Rondon, Netxibeth
    Reyes, Francia
    Borjas, Lisbeth
    Solis, Ernesto
    Mujica, Endrina
    Prieto, Carem
    Reyna, Nadia
    Velasco, Manuel
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (03) : 325 - 329
  • [40] Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrentLDLR mutations
    M. Chmara
    B. Wasąg
    M. Żuk
    J. Kubalska
    A. Węgrzyn
    M. Bednarska-Makaruk
    E. Pronicka
    H. Wehr
    J. C. Defesche
    A. Rynkiewicz
    J. Limon
    Journal of Applied Genetics, 2010, 51 : 95 - 106